ERBB2 and cancer: Numerous prior investigations have significantly contributed to the present understanding by examining ErbB2 and 14-3-3ζ-mediated effects on intracellular stiffness [17], MEC motility in soluble chemical gradients [20], cancer cell migration with respect to ligand availability [5], and motility-induced matrix remodeling [28].